The United States is the global leader in medical innovations. Due to the perverse incentives in our current healthcare system, patients are unable to afford and access these life-saving treatments. Biosimilars are lower-cost, nearly identical alternatives to complex biologic drugs. They have the potential to increase…
In terms of health innovation, the United States is a world leader. However, patients find it difficult to access and afford those life-saving treatments because of the perverse incentives that exist in our present healthcare system to prevent lower-cost medications from being sold. Biosimilars, which are inexpensive alternatives to difficult biologic drugs that are almost identical, have the ability to grow… In terms of health innovation, the United States is a world leader. However, patients have trouble accessing and affording those life-saving treatments because of the perverse incentives that exist in our current health care system to prevent lower-cost drugs from the market. Almost similar, less expensive alternatives to expensive biologic drugs called biosimilars have the potential to grow.
The United States is the global leader in medical innovations. Due to the perverse incentives in our current healthcare system, patients are unable to afford and access these life-saving treatments. Biosimilars are lower-cost, nearly identical alternatives to complex biologic drugs. They have the potential to increase…
